Clinical Trial Update: Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix [NA]

View source ↗

Summary

A clinical trial evaluating whether double-dose vaginal progesterone reduces preterm birth in twin pregnancies with a short cervix has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Progesterone (vaginal) (progesterone)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Premature Birth | NA | Status: TERMINATED